Cargando…
Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer
CD96 was identified as a novel immune checkpoint. However, the role of CD96 in the gastric cancer (GC) microenvironment remains fragmentary. This study aimed to probe the clinical significance of CD96 to predict prognosis and therapeutic responsiveness, and to reveal the immune contexture and genomi...
Autores principales: | Xu, Chang, Fang, Hanji, Gu, Yun, Yu, Kuan, Wang, Jieti, Lin, Chao, Zhang, Heng, Li, He, He, Hongyong, Liu, Hao, Li, Ruochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746045/ https://www.ncbi.nlm.nih.gov/pubmed/35997524 http://dx.doi.org/10.1111/cas.15537 |
Ejemplares similares
-
Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022) -
Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103(+)CD8(+) T cells conferring favourable prognosis
por: Li, Ruochen, et al.
Publicado: (2020) -
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer
por: Zhang, Puran, et al.
Publicado: (2022) -
Intratumoral CXCR5(+)CD8(+)T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer
por: Wang, Jieti, et al.
Publicado: (2021) -
Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients
por: Jin, Kaifeng, et al.
Publicado: (2021)